STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
Reported by STAT News · all stories from statnews.com
Editorial digest
The FDA is preparing to release updated guidance concerning artificial intelligence, alongside notable developments from Epic's recent user group meeting. This covers key areas of digital health innovation and regulation.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Trusted health newsroom8/19/2026
STAT+: What Epic did — and didn’t — say about AI at its annual meeting
Epic's annual meeting covered some AI topics, but omitted others.
- Trusted health newsroom8/26/2026
STAT+: AI biotech Insitro’s Daphne Koller on how to speed up clinical trials
Daphne Koller from Insitro discusses using artificial intelligence to accelerate clinical studies.
- Trusted health newsroom8/14/2026
STAT+: Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators
Epic's alleged anticompetitive actions are under federal and state investigation.
- Trusted health newsroom8/17/2026
STAT+: Epic confronts unprecedented challenges as it prepares to address customers and unveil road map
Epic faces significant challenges before its customer meeting and road map unveiling.
- Trusted health newsroom8/26/2026
STAT+: When it comes to women’s health, money talks
Funding is increasing for innovations in women's health.